TD Asset Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Hold |
193,092
| – | – | ﹤0.01% | 1023 |
|
|
2025
Q1 | $1.64M | Sell |
193,092
-22,924
| -11% | -$195K | ﹤0.01% | 1008 |
|
|
2024
Q4 | $3.02M | Sell |
216,016
-5,400
| -2% | -$75.6K | ﹤0.01% | 893 |
|
|
2024
Q3 | $5.14M | Buy |
221,416
+124,230
| +128% | +$2.88M | ﹤0.01% | 795 |
|
|
2024
Q2 | $1.97M | Buy |
97,186
+42,200
| +77% | +$854K | ﹤0.01% | 1004 |
|
|
2024
Q1 | $1.37M | Buy |
54,986
+19,800
| +56% | +$493K | ﹤0.01% | 1113 |
|
|
2023
Q4 | $636K | Sell |
35,186
-46,600
| -57% | -$843K | ﹤0.01% | 1267 |
|
|
2023
Q3 | $1.64M | Buy |
81,786
+58,200
| +247% | +$1.17M | ﹤0.01% | 1011 |
|
|
2023
Q2 | $602K | Hold |
23,586
| – | – | ﹤0.01% | 1230 |
|
|
2023
Q1 | $502K | Hold |
23,586
| – | – | ﹤0.01% | 1263 |
|
|
2022
Q4 | $698K | Buy |
23,586
+8,000
| +51% | +$237K | ﹤0.01% | 1215 |
|
|
2022
Q3 | $370K | Hold |
15,586
| – | – | ﹤0.01% | 1342 |
|
|
2022
Q2 | $262K | Sell |
15,586
-13,500
| -46% | -$227K | ﹤0.01% | 1363 |
|
|
2022
Q1 | $1.28M | Sell |
29,086
-2,500
| -8% | -$110K | ﹤0.01% | 1192 |
|
|
2021
Q4 | $1.92M | Buy |
+31,586
| New | +$1.92M | ﹤0.01% | 1143 |
|